Table 2.

Determination and comparison of hemodynamic parameters of patients in the three groups

Variables	Groups	0 h	12 h	24 h	36 h	48 h	72 h	P□
HR	I + V group	89.12±14.81	88.85±15.25	85.59±14.38	83.56±13.30	82.26±8.35	84.26±8.35	<0.001
	I + B group	89.15±10.65	85.60±9.16	84.35±11.16	80.18±8.42	80.45±5.28	83.45±8.28	<0.001
	I group	89.29±12.21	86.63±6.48	84.32±10.89	82.38±12.66	81.54±5.36	84.54±5.37	<0.001
	P*	0.950	0.592	0.989	0.0.284	0.339	0.329
	P**	0.939	0.248	0.555	0.565	0.257	0.265
	P***	0.988	0.988	0.564	0.100	0.112	0.100
SpO2	I + V group	95.74±2.18	96.03±1.63	95.89±1.81	96.30±2.22	96.88±2.12	96.58±2.11	<0.001
	I + B group	95.15±1.77	94.60±2.03	94.66±2.35	95.48±2.50	95.92±2.65	95.62±2.65	<0.001
	I group	95.34±1.50	95.12±2.28	94.89±2.04	95.38±1.83	96.38±1.67	96.08±1.67	<0.001
	P*	0.568	0.137	0.529	0.811	0.230	0.213
	P**	0.211	0.010	0.007	0.018	0.197	0.211
	P***	0.069	<0.001	0.001	0.033	0.382	0.368
MAP	I + V group	86.27±12.20	86.05±11.84	84.06±8.95	83.32±9.95	83.26±9.49	85.26±9.48	0.40
	I + B group	89.45±10.74	86.78±12.60	83.89±7.40	82.18±8.97	81.22±9.72	83.22±9.72	<0.001
	I group	87.57±10.35	88.92±7.98	86.06±9.48	83.17±8.62	83.28±9.02	85.28±9.06	<0.001
	P*	0.338	0.269	0.155	0.543	0.214	0.215
	P**	0.506	0.136	0.187	0.926	0.991	0.988
	P***	0.104	0.912	0.912	0.482	0.217	0.203

I + V group: Received ipratropium bromide and budesonide via a nebulizer. I + B group: In addition to ipratropium bromide, received the violet flower extract syrup. I group: Received ipratropium bromide alone via a nebulizer. HR: Heart Rate, SpO2: oxygen saturation, MAP: Mean Arterial Pressure. □: In the inter-group comparison: Level of significance for comparing each group in the follow-up. In the intra-group comparison, three comparisons have been made as follows: *Level of significance for comparing I group vs I + B group, **Level of significance for comparing I group vs I + V group, ***Level of significance for comparing I + B group vs I + V group